article thumbnail

What We Learned From Cybersecurity Attacks in Healthcare in 2022

MedCity News

In 2022, the healthcare sector is on track to meet or exceed the more than 50.4 million patient records that were breached last year. As we look ahead to 2023, increasing cybersecurity budgets will be a necessity for healthcare organizations, despite their tight financial situations.

article thumbnail

Report: MA Insurers Denied 3.4M Prior Authorization Requests in 2022

MedCity News

of prior authorization requests submitted to MA insurers were denied in 2022, according to a recent KFF report. Prior Authorization Requests in 2022 appeared first on MedCity News. About 7.4% Of these denials, only 9.9% were appealed. The post Report: MA Insurers Denied 3.4M

Insurance 291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 Highlights from HLTH 2022 [Sponsored]

MedCity News

Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.

article thumbnail

Report: Medicare Spending Reached $744B in 2022

MedCity News

A new KFF analysis showed that Medicare spending per person increased to $15,700 in 2022 from $5,800 in 2000, representing a 4.6% average annual growth.

article thumbnail

Going to Market Smarter in the New Economy

In 2022, as companies continue to move more functions online, employees will take a more virtual -- and flexible -- mindset and lifestyle in parallel to the digitization of businesses. The fight to find new customers and retain existing ones is the biggest business challenge for many companies.

article thumbnail

Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition

MedCity News

The two companies have been partners in hematological malignancies since 2022. Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications.

Biopharma 309
article thumbnail

Drug Approvals in 2022: A Recap of Notable FDA Regulatory Decisions

MedCity News

Fewer new drugs won FDA approvals in 2022 compared to previous years, but some of the products that passed regulatory muster are indicative of trends expected to continue into 2023. For example, more gene and cell therapies are on track to face regulatory decisions in the coming year.

FDA 327
article thumbnail

The ABC’s of Recruiting for Gen Z

In 2022, society has fully immersed itself in the web and all it has to offer - and no one more so than those of Generation Z. Take a look around you at any given moment, and somebody is likely surfing the web on their phone.

article thumbnail

What We Learned From Our Own Data-Driven ABM Strategy

So, what does ABM look like in 2022? Analysts and professionals alike tend to argue that account based marketing (ABM) is not new. On the surface, this is an accurate statement. However, ABM practitioners have evolved the strategy from development to implementation.

article thumbnail

Marketing-Led COVID-19 Growth Strategies: 2022 and Beyond

More than two years into the pandemic, COVID-19 is far from over. Businesses are tasked with beating pre-pandemic numbers, making marketing more essential than ever before.